About this trial
This project aims to compare Point-of-care capillary HbA1c (POC-cHbA1c) testing and fingerstick random blood glucose (RBG) testing in terms of type 2 diabetes detection rate and cost-effectiveness, in order to optimise current screening strategies for rural populations at high risk of diabetes in rural Dali, China, and to improve treatment adherence and self-management among people with diabetes.
Eligibility criteria
Qualifiers
Aged 18 years or above;
Permanent residents of Dali City who have lived locally for at least six consecutive months;
Registered as rural residents;
No known history of diabetes;
Disqualifiers
Known history of T2DM or currently receiving glucose-lowering treatment;
HbA1c testing with a clear result within the past three months, or completion of standardised diabetes screening within the past six months;
Pregnant or breastfeeding at the time of recruitment;
Active thyroid disease or other active endocrine disorders at recruitment, such as Cushing's syndrome or acromegaly;
Trial design
Treatments tested in this trial
- POC-cHbA1c
- Fingerstick RBG